Interest of the preventive and curative use of defibrotide on the occurrence and severity of sinusoidal obstruction syndrome after hematopoietic stem cell transplant in children

Defibrotide (DF) is indicated for the treatment of severe sinusoidal obstruction syndrome (SOS) following hematopoietic stem cell transplantation (HSCT), but its prophylactic use against SOS is not recommended yet. This study describes the impact of the preventive and curative use of DF on reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudebeck, Carl J., Renard, Cécile, Halfon‐Domenech, Carine, Ouachée‐Chardin, Marie, Philippe, Michael, Valla, Frederic V., Bertrand, Yves, Penel‐Page, Mathilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Cell Therapy/Stem Cell Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421979/
https://www.ncbi.nlm.nih.gov/pubmed/36051041
http://dx.doi.org/10.1002/jha2.480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421979/
https://www.ncbi.nlm.nih.gov/pubmed/36051041
http://dx.doi.org/10.1002/jha2.480

Ejemplares similares